The acetylator phenotype and ABO blood groups were evaluated in 55 normal subjects and in 156 diabetic patients [61 with Type 1 (insulin-dependent) diabetes and 95 with Type 2 (non-insulin-dependent) diabetes]. The prevalence of fast acetylators was significantly higher in the Type 1 diabetic patients (53%) than in the control subjects (29%). In the Type 2 diabetic patients the prevalence was 39%, and thus not signifi cantly different from the control or Type 1 diabetic groups. In the Type 2 diabetic patients, but not in the control or in the Type 1 diabetic subjects, an association between the fast acetylator phenotype and the B blood group was found. © 1984 Springer-Verlag.
CITATION STYLE
Pontiroli, A. E., Mosca, A., de Pasqua, A., Alcini, D., & Pozza, G. (1984). The fast acetylator phenotype in diabetes mellitus: abnormal prevalence and association with the ABO blood groups. Diabetologia, 27(2), 235–237. https://doi.org/10.1007/BF00273812
Mendeley helps you to discover research relevant for your work.